Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Adenocarcinoma”

1,990 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,990 results

Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableUnknownNCT05599737
What this trial is testing

Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA)

Who this might be right for
Prostate Adenocarcinoma
Centre Leon Berard 30
Testing effectiveness (Phase 2)Study completedNCT00022477
What this trial is testing

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 24
Testing effectiveness (Phase 2)Study completedNCT00003760
What this trial is testing

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center at San Antonio 3
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05444478
What this trial is testing

Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMicrowave AblationLiver Cancer+2 more
Sun Yat-sen University 274
Early research (Phase 1)Active Not RecruitingNCT02627443
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Metastatic Fallopian Tube CarcinomaMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Ended earlyNCT00492440
What this trial is testing

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Cytheris SA 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04017650
What this trial is testing

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Who this might be right for
BRAF NP_004324.2:p.V600EMetastatic Colon AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+13 more
M.D. Anderson Cancer Center 38
Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Large-scale testing (Phase 3)UnknownNCT00006468
What this trial is testing

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Ended earlyNCT01200810
What this trial is testing

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00005848
What this trial is testing

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Not applicableStudy completedNCT00900016
What this trial is testing

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT05101356
What this trial is testing

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Who this might be right for
Advanced AdenocarcinomaAdvanced Malignant Solid NeoplasmMetastatic Adenocarcinoma+3 more
Tianhong Li 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT05010629
What this trial is testing

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Who this might be right for
Salivary Gland CancerRecurrent Salivary Gland CancerMetastatic Cancer+1 more
Glenn J. Hanna 35
Large-scale testing (Phase 3)Study completedNCT00005995
What this trial is testing

AE-941 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
AEterna Zentaris
Load More Results